Developing an HPV vaccine to prevent cervical cancer and genital wartsBRYAN, Janine T.Vaccine. 2007, Vol 25, Num 16, pp 3001-3006, issn 0264-410X, 6 p.Conference Paper

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesGIULIANO, Anna R; PALEFSKY, Joel M; CHANG, Yen-Hwa et al.The New England journal of medicine. 2011, Vol 364, Num 5, pp 401-411, issn 0028-4793, 11 p.Article

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccineJOURA, Elmar A; KJAER, Susanne K; GARCIA, Patricia et al.Vaccine. 2008, Vol 26, Num 52, pp 6844-6851, issn 0264-410X, 8 p.Article

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American womenPEREZ, Gonzalo; LAZCANO-PONCE, Eduardo; VUOCOLO, Scott et al.International journal of cancer. 2008, Vol 122, Num 6, pp 1311-1318, issn 0020-7136, 8 p.Article

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesGARLAND, Suzanne M; HERNANDEZ-AVILA, Mauricio; TADDEO, Frank J et al.The New England journal of medicine. 2007, Vol 356, Num 19, pp 1928-1943, issn 0028-4793, 16 p.Article

A novel Staphylococcus aureus vaccine : Iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelKUKLIN, Nelly A; CLARK, Desmond J; PANCARI, Gregory et al.Infection and immunity. 2006, Vol 74, Num 4, pp 2215-2223, issn 0019-9567, 9 p.Article

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18VILLA, Luisa L; AULT, Kevin A; KURMAN, Robert J et al.Vaccine. 2006, Vol 24, Num 27-28, pp 5571-5583, issn 0264-410X, 13 p.Article

Humoral, Mucosal, and Cell-Mediated Immunity Against Vaccine and Nonvaccine Genotypes After Administration of Quadrivalent Human Papillomavirus Vaccine to HIV-Infected ChildrenWEINBERG, Adriana; SONG, Lin-Ye; SAAH, Alfred et al.The Journal of infectious diseases. 2012, Vol 206, Num 8, pp 1309-1318, issn 0022-1899, 10 p.Article

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trialMUNOZ, Nubia; MANALASTAS, Ricardo; BAUTISTA, Oliver et al.Lancet (British edition). 2009, Vol 373, Num 9679, pp 1949-1957, issn 0140-6736, 9 p.Article

Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in AustraliaNEWALL, Anthony T; BROTHERTON, Julia M. L; MACLNTYRE, C. Raina et al.Clinical infectious diseases. 2008, Vol 46, Num 11, pp 1647-1655, issn 1058-4838, 9 p.Article

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6,11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions : a combined analysis of three randomised clinical trialsJOURA, Elmar A; LEODOLTER, Sepp; STEBEN, Marc et al.Lancet (British edition). 2007, Vol 369, Num 9574, pp 1693-1702, issn 0140-6736, 10 p.Article

Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck CancerAPPLEBAUM, Katie M; FURNISS, C. Sloane; ZEKA, Ariana et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 23, pp 1801-1810, issn 0027-8874, 10 p.Article

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 YearsBROWN, Darron R; KJAER, Susanne K; AULT, Kevin A et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 926-935, issn 0022-1899, 10 p.Article

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 YearsWHEELER, Cosette M; KJAER, Susanne K; AULT, Kevin A et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 936-944, issn 0022-1899, 9 p.Article

Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women : study design and cohort characteristicsSKJELDESTAD, Finn Egil; MEHTA, Vinay; ESSER, Mark T et al.Acta obstetricia et gynecologica Scandinavica. 2008, Vol 87, Num 1, pp 81-88, issn 0001-6349, 8 p.Article

Human papillomavirus 16 and head and neck squamous cell carcinomaFURNISS, C. Sloane; MCCLEAN, Michael D; SMITH, Judith F et al.International journal of cancer. 2007, Vol 120, Num 11, pp 2386-2392, issn 0020-7136, 7 p.Article

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV DetectionROBERTS, Christine C; SWOYER, Ryan; BRYAN, Janine T et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 5, pp 1899-1906, issn 0095-1137, 8 p.Article

Importance of Specimen Type in Detecting Human Papillomavirus DNA From the Female Genital TractROBERTS, Christine C; LIAW, Kai-Li; SKJELDESTAD, Finn Egil et al.Journal of medical virology. 2009, Vol 81, Num 9, pp 1620-1626, issn 0146-6615, 7 p.Article

Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomasBRYAN, Janine T; TADDEO, Frank; SKULSKY, Deemarie et al.Journal of medical virology. 2006, Vol 78, Num 1, pp 117-124, issn 0146-6615, 8 p.Article

Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles : Correlation with competitive radioimmunoassay titerBROWN, Darron R; BRYAN, Janine T; JANSEN, Kathrin U et al.The Journal of infectious diseases. 2001, Vol 184, Num 9, pp 1183-1186, issn 0022-1899Article

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccineROWHANI-RAHBAR, Ali; MAO, Constance; HUGHES, James P et al.Vaccine. 2009, Vol 27, Num 41, pp 5612-5619, issn 0264-410X, 8 p.Article

Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16 : A 2-year randomized controlled clinical trialPOLAND, Gregory A; JACOBSON, Robert M; KOUTSKY, Laura A et al.Mayo Clinic proceedings. 2005, Vol 80, Num 5, pp 601-610, issn 0025-6196, 10 p.Article

Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccineROWHANI-RAHBAR, Ali; ALVAREZ, Frances B; BRYAN, Janine T et al.Journal of clinical virology. 2012, Vol 53, Num 3, pp 239-243, issn 1386-6532, 5 p.Article

Study Comparing Human Papillomavirus (HPV) Real-Time Multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV Genotyping PCR AssayIFTNER, Thomas; GERM, Liesje; SWOYER, Ryan et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 7, pp 2106-2113, issn 0095-1137, 8 p.Article

H5N1 Virus Causes Significant Perturbations in Host Proteome Very Early in Influenza Virus-Infected Primary Human Monocyte-Derived MacrophagesYAN CHEUNG, Chung; CHAN, Eric Y; KRASNOSELSKY, Alexei et al.The Journal of infectious diseases. 2012, Vol 206, Num 5, pp 640-645, issn 0022-1899, 6 p.Article